Wall Street on course for February loss, first in 10
months
Send a link to a friend
[February 28, 2018]
By Sruthi Shankar
(Reuters) - Wall Street looked set to open
flat on Wednesday, on track for loss on the month in February, as
concerns over rising interest rates and their downward impact on stock
markets dominated chatter among traders.
A monthly loss for the S&P 500 <.SPX> and the Dow Industrials <.DJI>
would be their first fall since March of last year.
Federal Reserve chair Jerome Powell, in his debut testimony to Congress
on Wednesday, struck a mildly hawkish tone, noting inflation had risen
since December and vowing to prevent the economy from overheating.
That prompted traders to raise the odds on the Fed squeezing in another
rate hike beyond the three already expected this year. Futures tied to
target policy rates now price in a one-in-three chance of rates rising
by a full percentage point in 2018.

World stocks were also set to snap a record 15-month winning streak due
to data signaling a slowdown in China's manufacturing and Japan's
industrial output.
A Reuters analysis showed global investors cut their equity exposure to
a three-month low in February, though most still expect stocks to test
new highs despite rising bond yields.
[to top of second column] |

Traders work on the floor of the New York Stock Exchange, (NYSE) in
New York, U.S., February 26, 2018. REUTERS/Brendan McDermid

At 6:48 a.m. ET, Dow e-minis <1YMc1> were up 8 points, S&P 500 e-minis <ESc1>
slipped 0.5 points and Nasdaq 100 e-minis <NQc1> was 1 point higher.
Among early decliners was No. 2 home improvement chain Lowe's <LOW.N>, whose
shares slumped 7 percent after the company's quarterly profit missed estimates
as margins fell.
Celgene <CELG.O> fell about 7 percent after U.S. health regulators rejected the
company's application seeking approval of a key multiple sclerosis drug.
The U.S. Commerce Department is set to release its second revised estimate of
the fourth-quarter gross domestic product at 8:30 a.m. ET. The economy is likely
to have expanded at a 2.5 percent annual rate, compared with a previous estimate
of 2.6 percent.
Reading on the Fed's favored gauge of inflation, personal consumption
expenditure, is due on Thursday.
(Reporting by Sruthi Shankar in Bengaluru; Editing by Anil D'Silva)
[© 2018 Thomson Reuters. All rights
reserved.] Copyright 2018 Reuters. All rights reserved. This material may not be published,
broadcast, rewritten or redistributed.
Thompson Reuters is solely responsible for this content. |